Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center

Henry Hiep Vo, Carrie Cartwright, I. Wen Song, Daniel D. Karp, Graciela M.Nogueras Gonzalez, Yuran Xie, Michael Karol, Matthew Hitron, David Vining, Apostolia Maria Tsimberidou

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center'. Together they form a unique fingerprint.

Medicine & Life Sciences